Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Phase 2 Completed
18 enrolled
EREVA
Phase 4 Completed
196 enrolled
EBV-RIS
Completed
156 enrolled
MS; FTY720
Completed
4,000 enrolled
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
Phase NA Completed
194 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
Completed
610 enrolled
Exploring Accessible Beauty for Individuals With Upper Extremity Deficits
Completed
57 enrolled
SONICS
Completed
49 enrolled
BETAPREDICT
Completed
162 enrolled
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
Phase NA Completed
114 enrolled
COVIVAC-ID
Phase NA Completed
377 enrolled
An Observational Post-Marketing Safety Registry of Sativex®
Completed
978 enrolled
Neurology Inpatient Clinical Education Trial
Phase NA Completed
50 enrolled
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Completed
114 enrolled
COMO-GMC
Completed
5,940,299 enrolled
PReSuTINeB
Phase 2 Completed
48 enrolled
Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
Phase 2/3 Completed
50 enrolled 20 charts
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
Phase NA Completed
1 enrolled 4 charts
PROmyBETAapp
Completed
96 enrolled
Central Pain Study for ABX-1431
Phase 1 Completed
9 enrolled
CHAMPIONS10
Phase 4 Completed
155 enrolled 10 charts
Assessment of Patients With Multiple Sclerosis (MS)
Completed
1,388 enrolled
Post-transfusion Platelet Count
Completed
80 enrolled